A twice-yearly injection could transform HIV prevention, yet questions of access illuminate deeper dilemmas surrounding public financing, pharmaceutical pricing, and contracting global health funding. Al Jazeera’s Mikail Malik investigates the struggle over equitable distribution.
Published On 30 Sep 2026
